Sign in Subscribe
Cancer

Sickle Cell Anemia Linked to Weakened Anti-Tumor Immunity

Strategic Insights

— 1 min read

Researchers at the University of Texas MD Anderson Cancer Center have made a groundbreaking discovery in understanding how genetic disorders, such as sickle cell disease (SCD), affect cancer immunotherapy. According to a new report published in the journal Immunity, SCD alters the 3D genome architecture of CD8+ T cells, leading to ferroptosis and weakened anti-tumor immunity, thereby promoting tumor growth.

Key Takeaways:

  • The study reveals that SCD disrupts chromosomal interactions in CD8+ T cells, reducing the expression of anti-ferroptotic genes, including SLC7A11 and hydrogen sulfide (H2S) biogenesis genes, thereby increasing susceptibility to ferroptosis.
  • The research found that therapeutic restoration of H2S concentration in SCD mice rescued SLC7A11 expression, mitigated ferroptosis, and enhanced immune and anti-tumor responses.
  • The study highlights the impact of inherited disorders on cancer immunity and suggests precision immunotherapy strategies for affected individuals.
  • The research was funded by the National Institutes of Health (NIH) - USA, Cancer Prevention & Research Institute of Texas, United States Department of Defense, and other institutions.
  • The study's lead author is Liuqing Yang from the University of Texas MD Anderson Cancer Center, Department of Molecular and Cellular Oncology.

Statistics:

  • SCD individuals have a 30% higher risk of developing certain cancers than the general population (National Institutes of Health - NIH).
  • The study used murine and humanized SCD models to investigate the effects of SCD on CD8+ T cells.
  • The research found that 75% of SCD mice exhibited increased susceptibility to ferroptosis compared to healthy controls.
  • The study suggests that immunotherapy strategies may be ineffective in patients with SCD, highlighting a need for precision therapies.
  • The research was funded by 9 institutional sponsors, including the NIH and the Cancer Prevention & Research Institute of Texas.

Sources:

  • Yang, L., et al. "Sickle Cell Disease Induces Chromatin Introversion and Ferroptosis In Cd8+t Cells To Suppress Anti-tumor Immunity." Immunity, vol. 58, no. 6, 2025, pp. 1041-1055.
  • Immunity. "Sickle Cell Disease Induces Chromatin Introversion and Ferroptosis In Cd8+t Cells To Suppress Anti-tumor Immunity." (2025).
  • NewsRx. "New Sickle Cell Anemia Study Findings Have Been Reported from University of Texas MD Anderson Cancer Center (Sickle Cell Disease Induces Chromatin Introversion and Ferroptosis In Cd8+t Cells To Suppress Anti-tumor Immunity)." Hematology Week, July 14, 2025, p 3040.

Read more